Azilect 0.5 mg

AZILECT 0.5 MG tablets contain rasagiline mesylate, a medication used to manage symptoms of Parkinson's disease. This oral tablet is manufactured by Teva Canada Limited and comes in a pack of 30.

AZILECT 0.5 MG tablets are primarily used to help manage the symptoms of Parkinson's disease. Rasagiline mesylate, the active ingredient, is often prescribed to improve mobility and reduce tremors. This medication is part of a broader treatment plan that may include other therapies to address the progressive nature of Parkinson's disease.

Common effects of AZILECT 0.5 MG tablets may include dizziness, nausea, and headache. Some users might experience changes in blood pressure or sleep disturbances. It's important to monitor how your body responds to this medication and consult a healthcare provider if any effects are concerning.

AZILECT 0.5 MG tablets should be handled with care. Store them at room temperature away from moisture and heat. Keep this medication out of reach of children and pets. Always follow the guidance of a healthcare professional regarding the use of this medication.

AZILECT 0.5 MG tablets may interact with certain medications, including other Parkinson's disease treatments, antidepressants, and some pain relievers. Consuming alcohol while taking this medication can increase the risk of side effects. Always inform your healthcare provider about all medications and supplements you are taking.